Perrigo | PRGO - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
AbbVie USD 4.29B 73M 2026-06
Abbott USD 5.94B 642M 2026-06
Bayer EUR 5.23B 731M 2026-03
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Coherus Biosciences USD 4.04M 324K 2025-12
Corcept Therapeutics USD 4.06M 1.18M 2026-06
Dr.Reddys Laboratories INR 39.22B 1.52B 2026-06
Eli Lilly USD 3.58B 205M 2026-03
J&J USD 8B 67M 2026-06
Merck USD 2.94B 380M 2026-03
Nestle CHF 23.12B 1.97B 2026-06
Pacira USD 50.74M 3.89M 2026-03
Perrigo USD 643.7M 103.7M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 140.76M 9.53M 2026-03
Reckitt Benckiser GBP 2.75B 1.34B 2024-12
Sanofi EUR 3.02B 656M 2026-06
Supernus Pharmaceuticals USD 49.04M 1.5M 2026-03
Teva Pharmaceutical Industries USD 1.98B 30M 2026-06
Xeris Pharmaceuticals USD 10.57M 3.08M 2026-03
Zoetis USD 672M 71M 2026-03